Risk factors for patient-important upper gastrointestinal bleeding: A protocol and statistical analysis plan for a secondary analysis of the REVISE (Re-Evaluating the Inhibition of Stress Erosions) trial
Abstract
Background: While studies have reported risk factors for clinically-important upper gastrointestinal bleeding among critically ill patients, the risk factors for patient-important upper gastrointestinal bleeding, as defined by ICU survivors and family members, are unknown. Further, although trials show that stress ulcer prophylaxis with pantoprazole decreases the risk of upper gastrointestinal bleeding, some research suggests that mortality may be increased among patients with high illness severity who are exposed to pantoprazole. The risk of death during critical illness is greater than the risk of upper gastrointestinal bleeding.
Objective: To identify risk factors for patient-important upper gastrointestinal bleeding among invasively ventilated critically ill adults, taking into account illness severity and the competing risk of death.
Materials and Methods: This pre-planned secondary analysis of the REVISE trial database will be guided by this protocol. We will use Cox proportional hazards regression analysis to assess the effect of candidate risk factors on the hazard rate of the primary outcome of time to patient-important upper gastrointestinal bleeding, considering the competing risk of death. We propose 2 sensitivity analyses. Secondary analyses will evaluate risk factors for clinically-important upper gastrointestinal bleeding, and another model will evaluate whether enteral nutrition attenuates the effect of pantoprazole on bleeding prevention compared to placebo by including an interaction term between pantoprazole vs. placebo and amount of enteral nutrition received.
Results: This study will identify conditions of critical illness which confer an increased risk of patient-important upper gastrointestinal bleeding in critically ill patients, and factors that decrease the risk.
Conclusions: The findings may inform bedside care, practice guidelines, and the design of future studies.
Keywords
Full Text:
PDFReferences
Burns KEA, Misak C, Herridge M et al. Patient and family engagement in critical care in the ICU: Untapped opportunities and under-recognized challenges. Am J Respir Crit Care Med. 2018;198(3):310-319. doi: 10.1164/rccm.201710-2032CI.
Gyllensten H, Björkman I, Jakobsson Ung E et al. A national research centre for the evaluation and implementation of person-centred care: Content from the first interventional studies. Health Expect 2020;23(5):1362-1375. doi: 10.1111/hex.13120.
Beverly EA, Wray LA, LaCoe CL, Gabbay RA. Listening to older adults' values and preferences for type 2 diabetes care: A qualitative study. Diabetes Spectr 2014;27(1):44-9. doi: 10.2337/diaspect.27.1.44.
Granholm A, Anthon CT, Kjær M-BN et al. Patient-important outcomes other than mortality in contemporary ICU trials: a scoping review. Critical Care Medicine 2022;50(10):e759-e71.
Cook DJ, Fuller H, Guyatt GH, for the Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330:377-381.
Cook DJ, Guyatt GH, Marshall J et al for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for prevention of upper gastrointestinal bleeding in patients requiring ventilation. N Engl J Med 1998;338(12):791-797.
Krag M, Perner A, Wetterslev J et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult ICU patients. Intensive Care Med 2015;41(5):833.
Krag M, Marker S, Perner A for the SUPICU Investigators. Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 2018;379(23):2199-2208. doi: 10.1056/NEJMoa1714919.
Young PJ, Bagshaw SM, Forbes AB et al. Effect of stress ulcer prophylaxis with proton pump inhibitors vs. histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation: The PEPTIC Trial. JAMA 2020;18;323(7):616-626.
Vanstone MG, Krewulak K, Taneja S et al for the Canadian Critical Care Trials Group. Patient-important upper gastrointestinal bleeding in the ICU: A mixed-methods study of patient and family perspectives. J Crit Care 2024;81:154761.
Cook DJ, Deane A, Lauzier F et al for the REVISE Trial Investigators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Stress ulcer prophylaxis for invasively ventilated patients: A randomized trial. N Engl J Med 2024;391(1):9-20. DOI: 10.1056/NEJMoa2404245.
*Deane A, *Alhazzani W, Finfer S et al; *co-first authors for the REVISE Investigators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. REVISE Protocol. BMJ Open 2023;13(11):e075588. doi: 10.1136/bmjopen-2023-075588.
Heels-Ansdell D, Billot L, Thabane L et al for the REVISE Investigators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. REVISE: Re-Evaluating the Inhibition of Stress Erosions in the ICU: Statistical analysis plan for a randomized trial. Trials 2023;24.796.doi.org/10.1186/s13063-023-07794-z.
Granholm A, Zeng L, Dionne JC et al for the GUIDE Group. Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 2019;45(10):1347-1359. doi: 10.1007/s00134-019-05751-6.
Cook DJ, Griffith L, Walter S, Guyatt G, Meade M, Heyland D, Kirby A, Tryba M, for the Canadian Critical Care Trials Group. The attributable mortality and length of ICU stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5(6):368-375. (also at http://www.ccforum.com).
Harrell FE, Lee KL. Verifying assumptions of the Cox proportional hazards model. Proceedings of the Eleventh Annual. SAS User’s Group International Conference. Cary, N.C.: SAS Institute, Inc. 1986:823-828. 16.
Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241. 17.
Angriman F, Ferreyro BL, Harhay MO et al. Accounting for competing events when evaluating long-term outcomes in survivors of critical illness. Am J Respir Crit Care Med. 2023;208(11):1158-1165. doi: 10.1164/rccm.202305-0790CP.
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
Wei LJ. Testing goodness of ft for proportional hazards model with censored observations. J Am Stat Assoc. 1984;79:649–52.
Cook DJ, Swinton M, Krewulak K et al. What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectives. BMJ Open 2023:13(5):e070966.
Cook DJ, Deane A, Dionne JC et al for the REVISE Trial Investigators and the Canadian Critical Care Trials Group. Adjudication of a primary trial outcome: Results of a calibration exercise and protocol for a large international Trial. Contemporary Clinical Trials Communications 2024;39:101284.
Peduzzi P, Concato J, Feinstein AR et al. Importance of events per independent variable in proportional hazards regression analysis. II: Accuracy and precision of regression estimates. J Clin Epi 1995;48(12):1503-1510.
Borthwick M, Granholm A, Marker S et al for the SUP-ICU investigators. Associations between enteral nutrition and outcomes in the SUP-ICU trial: Protocol for exploratory post hoc analyses. Acta Anaesthesiol Scand 2023;67(4):481-486. doi: 10.1111/aas.14194.
Cook DJ, Heyland D, Griffith LE et al for the Canadian Critical Care Trials Group. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med 1999; 27:2812-2817.
Stravitz RT, Ellerbe C, Durkalski V et al for the Acute Liver Failure Study Group. Bleeding complications in acute liver failure. Hepatology 2018;67(5):1931-1942. doi: 10.1002/hep.29694.
Barletta JF, Mangram AJ, Sucher JF et al. Stress Ulcer Prophylaxis in Neurocritical Care. Neurocrit Care 2018;29:344–357. https://doi.org/10.1007/s12028-017-0447-y
https://cihr-irsc.gc.ca/e/50836.html
Granholm A, Krag M, Marker S et al for the SUP-ICU Investigators. Predictors of gastrointestinal bleeding in adult ICU patients in the SUP-ICU trial. Acta Anaesthesiol Scand 2021;65(6):792-800. doi: 10.1111/aas.13805.
Wang Y, Parpia S, Ge L et al. Proton pump inhibitors to prevent gastrointestinal bleeding: An updated meta-analysis. NEJM Evidence 2024; doi: 10.1056/EVIDoa2400134.
MacLaren R, Dionne JC, Granholm A et al. Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med 2024;52(8):e421-e430. doi: 10.1097/CCM.0000000000006330. Supplement http://links.lww.com/CCM/H544.
DOI: https://doi.org/10.23954/osj.v10i1.3700
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Open Science Journal (OSJ) is multidisciplinary Open Access journal. We accept scientifically rigorous research, regardless of novelty. OSJ broad scope provides a platform to publish original research in all areas of sciences, including interdisciplinary and replication studies as well as negative results.